Corteva (NYSE:CTVA) Reaches New 12-Month High After Analyst Upgrade

Shares of Corteva, Inc. (NYSE:CTVA) reached a new 52-week high on Thursday after Oppenheimer raised their price target on the stock from $89.00 to $95.00. Oppenheimer currently has an outperform rating on the stock. Corteva traded as high as $88.57 and last traded at $88.5550, with a volume of 2140586 shares trading hands. The stock had previously closed at $86.94.

CTVA has been the subject of several other research reports. Jefferies Financial Group upped their price target on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Morgan Stanley boosted their price objective on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. Mizuho upped their target price on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a report on Tuesday, July 14th. Bank of America increased their target price on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research report on Monday, July 20th. Finally, The Goldman Sachs Group lifted their price target on Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a report on Tuesday, April 14th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat.com, Corteva has a consensus rating of “Moderate Buy” and an average target price of $90.19.

Key Stories Impacting Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Oppenheimer raised its price target on Corteva to $95 from $89 and kept an “outperform” rating, signaling confidence in further upside for the stock.
• Positive Sentiment: Zacks upgraded Corteva to Rank #2 (Buy), citing improving earnings prospects ahead of the company’s upcoming results.
• Positive Sentiment: Analysts expect Q2 earnings growth as premium seed demand, new products, and productivity gains help offset pricing and inflation pressure. Corteva Set to Report Q2 Earnings: What Investors Should Expect
• Neutral Sentiment: Corteva declared a quarterly dividend of $0.18 per share, payable September 15 to shareholders of record on September 1, which supports the stock’s income profile but is not a major growth catalyst. Corteva Declares Quarterly Dividend
• Neutral Sentiment: The company is set to report Q2 earnings soon, and investors are awaiting confirmation that demand and operating efficiency trends are holding up. Corteva (CTVA) Projected to Release Quarterly Earnings on Thursday

Institutional Investors Weigh In On Corteva

A number of hedge funds and other institutional investors have recently bought and sold shares of CTVA. Drummond Knight Asset Management Pty Ltd acquired a new stake in Corteva in the fourth quarter worth about $25,713,000. Arbejdsmarkedets Tillaegspension acquired a new position in shares of Corteva during the fourth quarter valued at about $23,679,000. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Corteva by 23.5% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock valued at $7,378,000 after purchasing an additional 20,957 shares during the last quarter. Leonteq Securities AG acquired a new stake in Corteva in the 4th quarter worth approximately $2,350,000. Finally, Brandes Investment Partners LP boosted its stake in Corteva by 1.1% in the 4th quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock worth $155,009,000 after purchasing an additional 24,985 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

The company has a market cap of $59.68 billion, a PE ratio of 52.49, a P/E/G ratio of 2.69 and a beta of 0.56. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The firm’s 50-day simple moving average is $81.39 and its two-hundred day simple moving average is $78.91.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same quarter last year, the company posted $1.13 earnings per share. The business’s quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts anticipate that Corteva, Inc. will post 3.76 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. Corteva’s dividend payout ratio (DPR) is 42.35%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.